View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Ipsen appoints Michelle C. Werner as EVP, President of North America

Ipsen appoints Michelle C. Werner as EVP, President of North America PARIS, FRANCE, 12 March 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today the appointment of Michelle C. Werner as Executive Vice President (EVP), President of North America, effective 23 March 2026. Michelle will serve on the Executive Leadership Team (ELT) and will report directly to Ipsen’s Chief Executive Officer (CEO), David Loew. “I am very pleased to welcome Michelle to Ipsen and to the Executive Leadership Team. She brings a wealth of experience in leading teams both in the U.S. and around the world and has...

 PRESS RELEASE

RUBIS:  Full-Year 2025 results - Another record year - Net income Grou...

RUBIS:  Full-Year 2025 results - Another record year - Net income Group share up +19% Paris, 12 March 2026, 7:30am    Solid operating performance more than outweighed the unfavourable EUR/USD exchange-rate movements, driven by the steady execution of the Group ‘strategy€741m EBITDA, in the upper part of the €710-760m guidance range, +3% yoy reported Up +7% yoy to €772m at constant EUR/USD exchange rate and constant hyperinflation +19%1 yoy growth in Net income Group share of €309m, excluding 2024 capital gain from Rubis Terminal (RT) disposal (-10% yoy reported) 30th year of consecutive ...

 PRESS RELEASE

RUBIS: Résultats annuels 2025 - Nouvelle année record - Résultat net, ...

RUBIS: Résultats annuels 2025 - Nouvelle année record - Résultat net, part du Groupe en hausse de + 19 %  Paris, le 12 mars 2026, 07:30    La solide performance opérationnelle a compensé positivement les effets défavorables de la variation du taux de change EUR/USD, portée par l’exécution rigoureuse de la stratégie du Groupe.EBITDA de 741 M€, dans la partie haute de la fourchette de guidance de 710 à 760 M€, + 3 % en publié En hausse de +7 % à 772 M€ à taux de change EUR/USD constant et à hyperinflation constante. Résultat net, part du Groupe en hausse de + 19 %1 à 309 M€, hors plus-value...

 PRESS RELEASE

Transaction in Own Shares

Transaction in Own Shares ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 12 March 2026 – Endeavour Mining plc (LSE:EDV, TSX:EDV) (“the Company”) announces it has purchased the following number of its ordinary shares of USD 0.01 each from Stifel Nicolaus Europe Limited. Aggregated information Dates of purchase:11 March 2026Aggregate number of ordinary shares of USD 0.01 each purchased:12,000Lowest price paid per share (GBp):                4,682.00Highest price paid per share (GBp):        4,795.82Volume weighted average price paid per share (GBp):        4,776.85 Following the canc...

 PRESS RELEASE

WORLDLINE : Launch of the rights issue - Press release

WORLDLINE : Launch of the rights issue - Press release Not for release, publication or distribution, directly or indirectly, in or into Canada, Australia, Japan or South Africa. Worldline launches a share capital increase with preferential subscription rights for an amount of approximately €392 million, thus executing the final step of its c. €500 million share capital increase Paris, La Défense, 12 March 2026 – Worldline S.A. [ISIN: FR0011981968 – Euronext: WLN] (the “Company” or “Worldline”), a leading European operator of critical infrastructure and payment services, announces today t...

 PRESS RELEASE

Aalberts N.V.: Aalberts completes divestment Broen in Denmark

Aalberts N.V.: Aalberts completes divestment Broen in Denmark Utrecht, 12 March 2026 Aalberts N.V. announces the successful completion of regulatory approvals and closing conditions, finalising the divestment of BROEN A/S (Broen), headquartered in Denmark, generating an annual revenue of approximately EUR 82 million with 500 employees. In December 2025, Aalberts announced that an agreement was reached to divest 100% of the shares of Broen. Broen will become part of new strategic ownership, fully active in its core business. We would like to thank all employees of Broen for their loyalty a...

 PRESS RELEASE

WORLDLINE : Lancement augmentation de capital avec DPS - Communiqué

WORLDLINE : Lancement augmentation de capital avec DPS - Communiqué Ne doit pas être publié, diffusé ou distribué, directement ou indirectement, au Canada, en Australie, au Japon ou en Afrique du Sud. Worldline lance une augmentation de capital avec maintien du droit préférentiel de souscription d’un montant d’environ 392 millions d’euros, dernière étape de l’augmentation de capital d’environ 500 millions d’euros annoncée lors de sa Journée Investisseurs (Capital Markets Day) du 6 novembre 2025 Paris, La Défense, 12 Mars 2026 – Worldline S.A. [ISIN : FR0011981968 – Euronext : WLN] (la « S...

North Memorial Health Care, MN: Update upon revision of outlook to neg...

Our credit view of this issuer reflects its strong performance and growth at MGH, offset by its ongoing shift toward governmental payors at the flagship hospital.

ABGSC Capital Goods Research ... (+3)
  • ABGSC Capital Goods Research
  • Anders Idborg
  • Karl Bokvist

Four Corners Operating Partnership, LP: Update to credit analysis

Our credit view of this issuer reflects its stable cash flow, offset by its industry concentration.

Erol Danis ... (+2)
  • Erol Danis
  • Salih Koseoglu

Model Portfolio Update - Including Türkiye Sigorta to our model portfo...

We are adding Türkiye Sigorta to our Model Portfolio. We believe the company is well positioned to benefit from the current higher interest rate environment while maintaining structural profitability supported by its exposure to the agricultural insurance segment. Higher interest rates should support investment income: Türkiye Sigorta stands to directly benefit from the recent hike in market rates. The TLREF (Turkish Lira Overnight Reference Rate) has risen to around 40% from approximately 37%,...

Alpha Metallurgical Resources Inc: 1 director

A director at Alpha Metallurgical Resources Inc bought 25,000 shares at 176.226USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...

AES Corporation, (The): Update following affirmation

AES’s credit profile reflects its scale, diversification, and stable revenues, partially offset by elevated consolidated leverage.

Guy Sips
  • Guy Sips

Amoéba Announcing its first order from its partner Koppert

We welcome Amoéba announced its first order from its partner Koppert. As a result Amoéba delivered on its promise to become a commercial company. Recall that Amoéba's biocontrol activities are now structured around its subsidiary Green 4 Agro. Amoéba stressed that this first order is proof of the promising nature of its partnership with Koppert. We reiterate our Buy rating and € 1.5 Target Price.

 PRESS RELEASE

2025 full year results

2025 full year results 2025 full year results EBITDA and capacity targets achieved With SPRING: activities refocused, leaner organization and reduction in the number of countries 2025 full year results Turnover: +16% at constant exchange rates to 588 million euros, driven in particular by growth in third-party Services (+70%)EBITDA: 211.31 million euros in line with the target announced in September2  (between 200 and 220 million euros), stable at constant exchange rates compared to 2024, including the impacts of curtailment in BrazilNet loss (group share): at -128.1 million euros due t...

 PRESS RELEASE

RESULTATS ANNUELS 2025

RESULTATS ANNUELS 2025 RESULTATS ANNUELS 2025 Objectifs d’EBITDA et de capacité atteints Avec SPRING : activités recentrées, organisation allégée et réduction du nombre de pays Résultats annuels 2025 Chiffre d’affaires : +16% à taux de change constants à 588 millions d’euros, notamment porté par la croissance des Services pour clients tiers (+70%)EBITDA : 211,31 millions d’euros en ligne avec l’objectif annoncé en septembre2 (entre 200 et 220 millions d’euros), stable à taux de change constants par rapport à 2024, intégrant les impacts de l’écrêtement au BrésilPerte nette (part du gro...

 PRESS RELEASE

Full Year 2025 Trading Update

Full Year 2025 Trading Update Ad hoc announcement pursuant to Art. 53 LR AGAMREE continues to build strong commercial momentum, delivering 98% revenue growth Pratteln, Switzerland, March 12, 2026 – Santhera Pharmaceuticals (SIX: SANN) today provides a trading update for the fiscal year 2025. Dario Eklund, CEO of Santhera, said: “The strong commercial momentum we are seeing with AGAMREE® reflects growing adoption across our core European markets and through our global partners, expanding access for more patients with Duchenne muscular dystrophy worldwide. As we continue to broaden our geo...

 PRESS RELEASE

Melexis Strengthens Commitment to China with New Wholly Foreign-Owned ...

Melexis Strengthens Commitment to China with New Wholly Foreign-Owned Enterprise (WFOE) and Autonomous Regional Organization Tessenderlo-Ham, Belgium – 12 March 2026 – (Euronext Brussels: MELE), a global leader in micro-electronic semiconductor solutions, today announced the formal establishment of Melexis Integrated System (Shanghai) Co., Ltd, a Wholly Foreign-Owned Enterprise (WFOE). This is an important milestone in the company's China strategy, alongside a redesign of its regional organization. This development represents a critical step in Melexis’ global strategy, where accelerating...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch